Search

Search Constraints

You searched for: Author/Creator Hauser, Stephen

Search Results

2. Evaluation of no evidence of progression or active disease (nepad) in patients with primary progressive multiple sclerosis in the oratorio trial. Issue 5 (8th May 2017)

3. Preliminary results of the opera i and opera ii open-label extension study. Issue 5 (8th May 2017)

4. Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO. Issue 6 (7th December 2020)

5. 061 Ocrelizumab reduces disability progression independent of relapse activity in patients with relapsing multiple sclerosis (RMS) (ENCORE). Issue 6 (24th May 2018)

6. 177 Updated safety analysis of ocrelizumab in multiple sclerosis. Issue 12 (14th November 2019)

7. Identification of MS-specific serum miRNAs in an international multicenter study. Issue 5 (September 2018)